CLASTOGENIC FACTORS IN THE PLASMA OF CHERNOBYL ACCIDENT RECOVERY WORKERS - ANTICLASTOGENIC EFFECT OF GINKGO-BILOBA EXTRACT

被引:82
作者
EMERIT, I
OGANESIAN, N
SARKISIAN, T
ARUTYUNYAN, R
POGOSIAN, A
ASRIAN, K
LEVY, A
CERNJAVSKI, L
机构
[1] UNIV PARIS 06, F-7500 PARIS, FRANCE
[2] MINIST HLTH, INST MED RADIOL, DAVIDASHEN 375078, ARMENIA
[3] YEREVAN STATE UNIV, DEPT GENET, YEREVAN 375049, ARMENIA
关键词
D O I
10.2307/3579259
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Clastogenic factors are found in the plasma of persons irradiated accidentally or therapeutically. They persisted in the plasma of A-bomb survivors over 30 years. Clastogenic factors were found in 33 of 47 Chernobyl accident recovery workers (often referred to as liquidators) in a previous study (I. Emerit ct QI., J. Cancer Res. Clin. Oncol. 120, 558-561, 1994). In the present study, we show that there is a positive correlation between clastogenic activity and dose and that these biomarkers of oxidative stress can be influenced successfully by appropriate antioxidant treatment. With the authorization of the Armenian Ministry of Health, 30 workers were treated with antioxidants from Ginkgo biloba leaves. The extract EGb 761 containing flavonoids and terpenoids was given at a daily dose of 3 x 40 mg (Tanakan, IPSEN, France) during 2 months. The clastogenic activity of the plasma was reduced to control levels on the first day after the end of the treatment. A I-year follow-up showed that the benefit of the treatment persisted for at least 7 months. One-third of the workers again had clastogenic factors after 1 year, demonstrating that the process which produced clastogenic factors continued. However, the observation that antioxidants do not have to be given continuously is encouraging for intervention trials on a large-scale basis. These appear justified, since clastogenic factors are thought to be risk factors for the development of late effects of irradiation. (C) 1995 by Radiation Research Society
引用
收藏
页码:198 / 205
页数:8
相关论文
共 43 条
[1]  
AGGARWAL BB, 1993, LYMPHOKINE CYTOK RES, V12, P9
[2]   CLASTOGENIC INOSINE NUCLEOTIDE AS COMPONENTS OF THE CHROMOSOME BREAKAGE FACTOR IN SCLERODERMA PATIENTS [J].
AUCLAIR, C ;
GOUYETTE, A ;
LEVY, A ;
EMERIT, I .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1990, 278 (01) :238-244
[3]  
BARET A, 1983, MUTAT RES, V121, P1313
[4]   PROSTAGLANDIN SYNTHETASE INHIBITION BY FLAVONOIDS AND PHENOLIC-COMPOUNDS IN RELATION TO THEIR O2-.-SCAVENGING PROPERTIES [J].
BAUMANN, J ;
WURM, G ;
BRUCHHAUSEN, FV .
ARCHIV DER PHARMAZIE, 1980, 313 (04) :330-337
[5]  
Bors W, 1987, Free Radic Res Commun, V2, P289, DOI 10.3109/10715768709065294
[6]  
BORS W, 1990, ADV EXP MED BIOL, V264, P165
[7]  
CULCASI M, 1993, ADV GINKGO, V2, P153
[8]  
DEFREUDIS FV, 1991, GINKGO BILOBA EXTRAC
[9]  
EMERIT I, 1990, NATO ADV SCI I A-LIF, V189, P99
[10]   REACTIVE OXYGEN SPECIES, CHROMOSOME MUTATION, AND CANCER - POSSIBLE ROLE OF CLASTOGENIC FACTORS IN CARCINOGENESIS [J].
EMERIT, I .
FREE RADICAL BIOLOGY AND MEDICINE, 1994, 16 (01) :99-109